Homerton University Hospital is a hospital in Homerton in the London Borough of Hackney. It is managed by Homerton University Hospital NHS Foundation Trust.

There are 500 beds in Homerton University Hospital.

During the past decade, Homerton University Hospital conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 8 clinical trials were completed, i.e. on average, 34.8% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 4 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Homerton University Hospital" #1 sponsor was "Gilead Sciences" with 6 trials, followed by "Barts & The London NHS Trust" with 3 trials sponsored, "Imperial College London" with 3 trials sponsored, "University College, London" with 3 trials sponsored and "LumiraDx UK Limited" with 3 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Homerton University Hospital" #1 collaborator was "University College, London" with 3 trials as a collaborator, "University of Birmingham" with 3 trials as a collaborator, "Barts & The London NHS Trust" with 2 trials as a collaborator, "Barts and the London School of Medicine and Dentistry" with 2 trials as a collaborator and "Gilead Sciences" with 2 trials as a collaborator. Other collaborators include 40 different institutions and companies that were collaborators in the rest 44 trials.

According to Clinical.Site data, the most researched conditions in "Homerton University Hospital" are "HIV Infections" (7 trials), "Acquired Immunodeficiency Syndrome" (3 trials), "Atrial Fibrillation" (2 trials), "Breast Cancer" (2 trials) and "HIV" (2 trials). Many other conditions were trialed in "Homerton University Hospital" in a lesser frequency.

Most popular intervention types in "Homerton University Hospital" are "Drug" (17 trials), "Device" (7 trials), "Other" (7 trials), "Procedure" (7 trials) and "Diagnostic Test" (4 trials). Other intervention types were less common.

The name of intervention was led by "ATV" (4 trials), "FTC/TDF" (4 trials), "Cholecalciferol" (3 trials), "ATV Placebo" (2 trials) and "COBI" (2 trials). Other intervention names were less common.

The vast majority of trials in "Homerton University Hospital" are 35 trials for "All" genders, 8 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Homerton University Hospital". undefined are not yet recruiting, 9 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Homerton University Hospital, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Homerton University Hospital, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 15 trials that are defined as “Not Applicable".